Clinical Trials
24
Active:3
Completed:9
Trial Phases
3 Phases
Phase 1:5
Phase 3:3
Not Applicable:15
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (23 trials with phase data)• Click on a phase to view related trials
Not Applicable
15 (65.2%)Phase 1
5 (21.7%)Phase 3
3 (13.0%)No trials found
News
DiaMedica's DM199 Shows Promising Blood Pressure Reduction in Phase 2 Preeclampsia Trial
DiaMedica Therapeutics reported positive interim Phase 2 results for DM199 (rinvecalinase alfa) in treating preeclampsia, showing statistically significant reductions in both systolic and diastolic blood pressure.
First Clinical Trial of DM199 Launched to Combat Preeclampsia
Stellenbosch University initiates a clinical trial for DM199, a novel drug targeting the root cause of preeclampsia, a severe pregnancy complication.